198 related articles for article (PubMed ID: 25124998)
21. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.
Zhang W; Chang G; Cao L; Ding G
BMC Cardiovasc Disord; 2021 Feb; 21(1):74. PubMed ID: 33546604
[TBL] [Abstract][Full Text] [Related]
24. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.
Liebetrau C; Möllmann H; Dörr O; Szardien S; Troidl C; Willmer M; Voss S; Gaede L; Rixe J; Rolf A; Hamm C; Nef H
J Am Coll Cardiol; 2013 Sep; 62(11):992-8. PubMed ID: 23747779
[TBL] [Abstract][Full Text] [Related]
25. Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.
Glineur SF; De Ron P; Hanon E; Valentin JP; Dremier S; Nogueira da Costa A
Toxicol Sci; 2016 Jan; 149(1):89-97. PubMed ID: 26454886
[TBL] [Abstract][Full Text] [Related]
26. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
[TBL] [Abstract][Full Text] [Related]
27. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP.
Squire I; Quinn P; Narayan H; Khan S; Dhillon O; Ng K; Kelly D; Davies J; Ng L
Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862
[TBL] [Abstract][Full Text] [Related]
29. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease].
Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573
[TBL] [Abstract][Full Text] [Related]
30. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs.
Oerlemans MI; Mosterd A; Dekker MS; de Vrey EA; van Mil A; Pasterkamp G; Doevendans PA; Hoes AW; Sluijter JP
EMBO Mol Med; 2012 Nov; 4(11):1176-85. PubMed ID: 23023917
[TBL] [Abstract][Full Text] [Related]
31. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
Liu WX; Zhao H
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction.
Bauters C; Kumarswamy R; Holzmann A; Bretthauer J; Anker SD; Pinet F; Thum T
Int J Cardiol; 2013 Oct; 168(3):1837-40. PubMed ID: 23347612
[TBL] [Abstract][Full Text] [Related]
34. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.
Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS
Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399
[TBL] [Abstract][Full Text] [Related]
35. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction.
Olivieri F; Antonicelli R; Lorenzi M; D'Alessandra Y; Lazzarini R; Santini G; Spazzafumo L; Lisa R; La Sala L; Galeazzi R; Recchioni R; Testa R; Pompilio G; Capogrossi MC; Procopio AD
Int J Cardiol; 2013 Jul; 167(2):531-6. PubMed ID: 22330002
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction.
Cortez-Dias N; Costa MC; Carrilho-Ferreira P; Silva D; Jorge C; Calisto C; Pessoa T; Robalo Martins S; de Sousa JC; da Silva PC; Fiúza M; Diogo AN; Pinto FJ; Enguita FJ
Circ J; 2016 Sep; 80(10):2183-91. PubMed ID: 27593229
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic impact of circulating microRNA-208b and microRNA-499 in patients with acute coronary syndrome.
Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC
Biomark Med; 2020 Feb; 14(2):87-95. PubMed ID: 31789049
[No Abstract] [Full Text] [Related]
39. Circulating microRNAs and Outcome in Patients with Acute Heart Failure.
Seronde MF; Vausort M; Gayat E; Goretti E; Ng LL; Squire IB; Vodovar N; Sadoune M; Samuel JL; Thum T; Solal AC; Laribi S; Plaisance P; Wagner DR; Mebazaa A; Devaux Y;
PLoS One; 2015; 10(11):e0142237. PubMed ID: 26580972
[TBL] [Abstract][Full Text] [Related]
40. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
